Clinical Trial

Effect of Probiotic Intervention on Travel-Related Health Conditions During Short-Term Overseas Travel

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated September 17, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
International travel disrupts gut health through dietary changes, microbial exposure, and stress, often causing gastrointestinal symptoms like traveler's diarrhea and sleep disturbances. These shifts may increase antibiotic resistance risks. Probiotics may help stabilize gut microbiota and improve well-being during travel. This randomized, double-blind, placebo-controlled trial investigated whether probiotic supplementation mitigates gut microbiota perturbations, gastrointestinal symptoms, and sleep issues in adults traveling abroad. The investigators also assessed changes in anxiety, well-being, gut immunity, microbial function, and antibiotic resistance genes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-01.
Trial Details
NCT Number NCT07163819
Lead Sponsor Universiti Sains Malaysia
Collaborators: Tsinghua University Science and Technology
Conditions Healthy Adults
Enrollment 46 participants
Start Date 2025-07-31
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-17